Table 3.
pCR rate of different BMI categories by breast cancer subtypes
| pCR | Normal/underweight N (%) | Overweight N (%) | Obese N (%) | P | |
|---|---|---|---|---|---|
| HR+/HER2+ | No | 39 (61.9) | 27 (61.4) | 32 (66.7) | 0.83 |
| Yes | 24 (38.1) | 17 (38.6) | 16 (33.3) | ||
| HR+/HER2- | No | 105 (80.8) | 116 (89.2) | 93 (78.8) | 0.06 |
| Yes | 25 (19.2) | 14 (10.8) | 25 (21.2) | ||
| HR-/HER2+ | No | 7 (25.0) | 11 (35.5) | 15 (51.7) | 0.11 |
| Yes | 21 (75.0) | 20 (64.5) | 14 (48.3) | ||
| HR−/HER2− | No | 83 (65.4) | 58 (55.8) | 76 (60.8) | 0.33 |
| Yes | 44 (34.7) | 46 (44.2) | 49 (39.2) |
HR hormone receptor, HER2 human epidermal growth factor receptor 2, pCR pathological complete response